Comparison of Disease Progression From Prostate Cancer Diagnosis to Metastatic or Nonmetastatic Castrate‐Resistant Prostate Cancer (<scp>CRPC</scp>) Patients: <scp>CaPA</scp> Study

This real-world study showed that the time from initial PC diagnosis to castration resistance was significantly longer in nmCRPC than in mCRPC patients. The characteristics associated with a better prognosis at initial diagnosis and a better treatment response in nmCRPC patients might explain this difference in disease progression.

Authors

Institutions

Publication Details

Journal
Cancer Medicine
Published
2025-08-01
DOI
https://doi.org/10.1002/cam4.71149
Citations
1
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
1.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison of Disease Progression From Prostate Cancer Diagnosis to Metastatic or Nonmetastatic Castrate‐Resistant Prostate Cancer (CRPC) Patients: CaPA Study

Rui Dinis, Ricardo Borges, António Canelas, Inês Sequeira et al.
1 citations
Cancer Medicine
Prostate Cancer Treatment and Research
1.52
article

Comparison of Disease Progression From Prostate Cancer Diagnosis to Metastatic or Nonmetastatic Castrate‐Resistant Prostate Cancer (CRPC) Patients: CaPA Study

Rui Dinis, Ricardo Borges, António Canelas, Inês Sequeira, Paulo Azinhais, Ana Cristina Vasconcelos Fialho, Francisco Botelho, Carlos Rabaça, Susana Dias, Frederico Carmo Reis, Ferdinando Pereira, João Vasco Barreira, Hugo Coelho, José Carvalho, Luís Campos Pinheiro, José Palma dos Reis, Luís Abranches Monteiro, Pedro Costa, F. Vilá, António Patrício
article en
1 citations

Abstract

This real-world study showed that the time from initial PC diagnosis to castration resistance was significantly longer in nmCRPC than in mCRPC patients. The characteristics associated with a better prognosis at initial diagnosis and a better treatment response in nmCRPC patients might explain this difference in disease progression.

Cancer MedicineVol. 14(16)
Instituto Politécnico de Leiria (PT), Universidade Politécnica de Viana do Castelo (PT), Hospitais da Universidade de Coimbra (PT), Hospital de São João (PT), Unidade Local de Saúde de São José (PT), Hospital de São José (PT), Universidade Politécnica da Guarda (PT), Hospital Pedro Hispano (PT), Hospital do Espírito Santo (PT), SGS (Portugal) (PT), Centro Hospitalar do Tâmega e Sousa (PT), Hospital de São Bernardo (PT), Laboratório Edol (Portugal) (PT), Centro Hospitalar de Vila Nova de Gaia (PT), Hospital Garcia de Orta (PT), Instituto Português de Oncologia de Coimbra Francisco Gentil (PT), Hospital de Santa Maria (PT), Hospital Dr. Nélio Mendonça (PT), Centro Hospitalar do Baixo Vouga (PT)
Fundação Champalimaud, Cilag
Openalex Percentile: Top 15%
Prostate Cancer Treatment and Research
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.